A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma.

Jee Hun LeeJacob L SchmelzFred CramerJorge E RomagueraMaria BadilloMichael L Wang
Published in: British journal of haematology (2020)